Skip to main content

Table 2 Effects of donepezil on Aβ25-35-induced cell viability and LDH release (n = 6, mean ± SD)

From: Neuroprotective effects of donepezil against Aβ25-35-induced neurotoxicity

Groups

Cell viability

LDH

Control

100

100

25-35

57.35 ± 3.95*

164.57 ± 14.52*

25-35 + 1 μmol donepezil

71.83 ± 6.01

152.63 ± 11.35

25-35 + 5 μmol donepezil

79.61 ± 7.72**

129.26 ± 11.56**

25-35 + 10 μmol donepezil

86.37 ± 7.45**

124.21 ± 7.44**

25-35 + 20 μmol donepezil

88.98 ± 9.36**

129.66 ± 5.27**

25-35 + 50 μmol donepezil

87.35 ± 7.42**

138.25 ± 5.93**

P

0.004

0.000

  1. *P < 0.05 compared with the control group
  2. **P < 0.05 compared with the Aβ25-35 group. The concentration of Aβ25-35 administered to each group was 20 μmol/L